Extracorporeal membrane oxygenation for nonneonatal pulmonary and multiple-organ failure

Area of Science:

• Pediatric Critical Care Medicine
• Cardiopulmonary Support
• Respiratory Physiology

Background:

• Extracorporeal membrane oxygenation (ECMO) is established for neonatal respiratory failure.
• Its application in older children remains a subject of debate and investigation.
• Understanding outcomes in diverse pediatric populations is crucial for refining treatment protocols.

Purpose of the Study:

• To evaluate the efficacy and outcomes of ECMO in children aged 3 months to 16 years.
• To identify patient characteristics and diagnoses associated with survival and complications.
• To assess the role of ECMO in isolated versus multiorgan failure pediatric cases.

Main Methods:

• A retrospective analysis of 55 children (3 months–16 years) treated with venoarterial or venovenous ECMO over 13 years.
• Patient diagnoses included pneumonia, aspiration, ARDS, sepsis, near drowning, and others.
• Pre-ECMO blood gas parameters and ECMO duration were recorded; complications and survival rates were analyzed.

Main Results:

• Forty-five percent (25/55) of patients survived ECMO, with 21 long-term survivors.
• Complications included significant rates of cannulation site hemorrhage (40), renal failure (10), and neurological events (seizures, stroke).
• Survival was notably lower in patients with combined pulmonary, cardiac, and renal failure, or sepsis.

Conclusions:

• Extracorporeal membrane oxygenation (ECMO) can be a life-saving intervention for pediatric patients with isolated respiratory failure.
• The utility of ECMO in children experiencing multiorgan failure is less certain and associated with poorer outcomes.
• Further research is needed to optimize patient selection and management strategies for ECMO in critically ill children.